Haemodialysis activates phospholipase A2 enzyme

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 109-116

  Vishwanath, B S ^a   Fux, C A ^a   Uehlinger, D E ^a   Frey, B M ^a   Franson, R C ^b   Frey, F J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Biocompatible materials; Inflammation; Membranes artificial

Indexed keywords

ARACHIDONIC ACID; CELLULOSE ACETATE; CUPROPHANE; HEPARIN; PHOSPHOLIPASE A2;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; ENZYME ACTIVATION; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; SYNOVIAL FLUID;

EID: 0030044354     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027023     Document Type: Article

References (59)

1. Blagg CR. Acute complications associated with hemodialysis, In: Maher JF. ed. Replacement of Renal Function by Dialysis. Kluwer Academic Publishers, Dordrecht, 1989, 750
2. Blumenstein M, Schmidt B, Ward RA et al. Altered interleukin-1 production in patients undergoing hemodialysis. Nephron 1988; 50: 277-281
3. Walker JF, Lindsay RM, Peters SD et al. A sheep model to examine the cardiopulmonary manifestations of blood dialyzer interactions. ASAIO J 1983; 6: 123
4. Cheung AK, Parker CJ, Wilcox LA et al. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-1059
5. Pascual M, Schifferli JA. Absorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1993; 43: 903-911
6. Deppisch R, Tirz E, Hansch GM et al. Bioincompatibility - Perspectives in 1993. Kidney Int 1994; 45 [Suppl 44]: S77-S84
7. Daugirdas JT, Ing TS, Roxe DM et al. Severe anaphylactoid reactions to cuprammonium cellulose hemodiayzers. Arch Intern Med 1985; 145: 489-494
8. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int 1983; 24: 764-769
9. Betz M, Haensch G, Rauterberg E et al Cuprammonium membranes stimulate interleukin 1 release and arachidonic metabolism in monocytes in the absence of complement. Kidney Int 1988; 34: 67-73
10. Laude-Sharp M, Caroff M, Simard L et al Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990; 38: 1089-1094
11. Memoli B, Libetta C, Rampino T et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 42. 320-326
12. 2-microglobulin synthesis by activated late complement components. Am J Kidney Dis 1993; 21: 394-399
13. Herbelm A, Nguyen AT, Zingraff J et al Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor. Kidney Int 1990; 37: 116-125
14. Schindler R, Linnenweber S, Schulze M et al. Gene expression of interleukin-1b during hemodialysis. Kidney Int 1993; 43: 712-721
15. Tetta C, David S, Biancone L et al Role of platelet activating factor in hemodialysis. Kidney Int 1993; 43 [Suppl 39]: S154-S157
16. Gawaz MP, Ward RA. Effect of hemodialysis on platelet-derived thrombospondin. Kidney Int 1991; 40: 257-265
17. Malaise M, Lust C, Foidart JB et al. Letter to the Editor. N Engl J Med 1985; 312: 514-515
18. 2 and signal transduction. J Am Soc Nephr 1992; 3: 128-150
19. 1 macrophage-like cells for enhanced arachidonic acid metabolism. J Biol Chem 1990; 265: 8658-8664
20. 2 J Biol Chem 1991; 266: 14119-14127
21. 2 in rat mesangial cells. Biochem Biophys Res Commun 1991; 174: 268-275
22. Patriarca P, Beckerdite S, Elsbach P. Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochem Biophys Acta 1972; 260: 593-600
23. Rothut B, Russo-Marie F, Wood J et al Further characterization of the glucocorticoid-induced antiphospholipase protein 'Renocortin'. Biochem Biophys Res Commun 1983; 117: 878-884
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physical 1959; 37: 911-917
25. Gibaldi M, Perrier D. Pharmacokinetics. Marcel Dekker, New York, 1975; 293-296
26. Hendrikson RL, Kreuger ET, Keim PS. Amino acid sequence of phospholipase A2-a from the venom of Crotalus adamanteus. J Biol Chem 1977; 252: 4913-4921
27. 2(s); comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J 1993; 7: 339-348
28. 2 activity in rats. J Clin Invest 1993; 92: 1974-1980
29. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS 1990; 261: 171-174
30. 2 in human acute pancreatitis. Gastroenterology 1989; 97: 1521-1526
31. 2. J Biol Chem 1989; 264: 5768-5775
32. 2 activities in human platelet, monicyte. and neutrophil. Biochem Cell Biol 1993; 71: 331-339
33. 2 in plasma increases in uremia. Clin Chem 1990; 36. 198-200
34. Nakamura H, Kim DK, Philbin DM et al Heparin-enhanced plasma phospholipase A2 activity and prostacydin synthesis in patients undergoing cardiac surgery. J Clin Invest 1995; 95: 1062-1070
35. Brady HR. Serhan CN. The prostaglandins, leukotrienes, lipoxins, and platelet-activating factor. In: Sigal LH, Ron Y, eds. Immunology and Inflammation, McGraw-Hill, New York. 1994; 271-286
36. Schindler R, Lonnemann G, Shaldon S et al. Transcriptional activation but not synthesis of interleukin-1b and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93
37. Lonnemann G, Behme TC, Lenzner B et al. The permeability of dialyzer membrane to TNF alpha inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-68
38. Honkanen E, Gronhagen RC, Teppa AM et al. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991; 57: 283-287
39. Lonnemann G, Bingel M, Koch KM et al. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 1987; 6. 63-70
40. Luger A, Kovarik J, Stummvoll HK et al Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84-88
41. Caruana RJ, Lobel SA, Leffell MS et al Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients. Int J Artif Organs 1990; 13: 794-798
42. Tetta C, Camussi G, Turello E et al. Production of cytokines in hemodialysis. Blood Purif 1990; 8: 337-346
43. Powell AC, Bland L, Oettiger CW et al. Plasma interleukin-1 beta and tumor necrosis factor alpha do not increase during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991; 2: 1007-1013
44. Kolb G, Hoffken H, Muller T et al Kinetics of pulmonary leukocyte sequestration in man during hemodialysis with different membrane-types. Int J Artif Organs 1990; 13: 729-736
45. Nguyen AT, Lethias C, Zingraff J et al. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985; 28: 158-167
46. Vanholder R, Ringoir S, Dhondt A et al. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320-327
47. 2 in human polymorphonuclear leukocytes. Biochim Biophys Acta 1986; 879: 149-156
48. 2 and arthritis. Arthritis Rheum 1993; 36: 190-198
49. 2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Leukocyte Biol 1985; 38: 649-654
50. Bomalaski JS, Clark MA, Zurier RB. Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum 1986; 29: 312-318
51. 2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation 1988; 12: 549-561
52. 2 induces an inflammatory response in rabbit joints. J Immunol 1991; 146: 3904-3910
53. Harris ED JR. Rheumatoid arthritis; pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-1289
54. Gerber B, Horber FF, Robotti G et al. Distinct distribution of periarticular erosions of the bones of the hand in chronic renal failure. Am J Nephrol 1987; 7: 459-463
55. Ritz E, Krempien B, Mehls O et al Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int 1973; 4; 116-127
56. Brown EA, Arnold IR, Gower PE. Dialysis arthropathy: complication of long-term treatment with haemodialysis. Br Med J 1986; 292: 163-166
57. Sethi D, Muller BR, Brown EA et al. C-reactive protein in haemodialysis patients with dialysis arthropathy Nephrol Dial Transplant 1988. 3: 269-271
58. Ritz E, Bommer J. Beta-2-microglobulin-derived amyloid - problems and perspectives. Blood Purif 1988; 6: 61-68
59. Knudsen PJ, Ng AK, Liu Z. Beta-2-microglobulin synthesis is increased during activation of human monocytes. Blood Purif 1988; 6: 178-187